These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 10192189)

  • 1. Bismuth subsalicylate increases intracellular Ca2+, MAP-kinase activity, and cell proliferation in normal human gastric mucous epithelial cells.
    Gilster J; Bacon K; Marlink K; Sheppard B; Deveney C; Rutten M
    Dig Dis Sci; 2004 Mar; 49(3):370-8. PubMed ID: 15139483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of jack bean urease by organobismuth compounds.
    Murafuji T; Azuma T; Miyoshi Y; Ishibashi M; Rahman AF; Migita K; Sugihara Y; Mikata Y
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1510-3. PubMed ID: 16406781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori.
    Yakoob J; Abbas Z; Usman MW; Awan S; Naz S; Jafri F; Hamid S; Jafri W
    Microb Drug Resist; 2014 Aug; 20(4):305-9. PubMed ID: 23844851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organobismuth compounds: activity against Helicobacter pylori.
    Dahlgren A; Gløgård C; Gammelsaether M; Aasen AJ; Klaveness J; Berdal BP; Bergan T
    Scand J Gastroenterol; 1999 Feb; 34(2):135-7. PubMed ID: 10192189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of Helicobacter pylori infection: current status].
    Wagner S; Gebel M; Manns M
    Z Gastroenterol; 1993; 31(7-8):459-63. PubMed ID: 8379235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori and peptic ulcer disease. Reexamining the therapeutic approach.
    Fedotin MS
    Postgrad Med; 1993 Sep; 94(3):38-40, 43-5. PubMed ID: 8361941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori infection. The importance of eradication in patients with gastric disease.
    Bonagura AF; Dabezies MA
    Postgrad Med; 1996 Nov; 100(5):115-6, 119-20, 123-4 passim. PubMed ID: 8917328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori and peptic ulcer.
    Korman MG; Tytgat GN
    Scand J Gastroenterol Suppl; 1995; 210():92-6. PubMed ID: 8578219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Bismuth in the Eradication of Helicobacter pylori.
    Alkim H; Koksal AR; Boga S; Sen I; Alkim C
    Am J Ther; 2017; 24(6):e751-e757. PubMed ID: 26808355
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.